Cantor Fitzgerald Cuts Endo Pharma (ENDP) to Sell; Not Optimistic Restructuring
Tweet Send to a Friend
Cantor Fitzgerald downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Hold to Sell with a price target of $30.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
